Insulin resistance (IR) is a physiological condition characterized by reduced responsiveness of insulin-targeting tissues to high physiological insulin levels and is considered the pathogenic driver of many modern diseases, including metabolic syndrome, nonalcoholic fatty liver disease, atherosclerosis, and type 2 diabetes mellitus (T2DM) (1). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.